Overview

Clinical Trial Evaluating the Combination of Vandetanib and Dasatinib During and After Radiation Therapy (RT) in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG)

Status:
Completed

Trial end date:
2014-06-01

Target enrollment:

Participant gender:

Summary

This is a Phase I clinical trial evaluating the combination of vandetanib and dasatinib during and after radiation therapy (RT) in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG).

Phase:

Phase 1

Details

Lead Sponsor:

St. Jude Children's Research Hospital

Collaborators:

AstraZeneca
The Cure Starts Now Foundation
Tyler's Treehouse

Treatments:

Dasatinib